Reactome Pathway Database

Schema > Person > Entries

Ross, JS Show undefined attributes

created [InstanceEdit:6800597] Rothfels, Karen, 2015年09月29日

dbId 6800598

displayName Ross, JS

firstname Jeffrey S

initial JS

publications

[LiteratureReference:9831359] Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted Therapies
[LiteratureReference:9647018] Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies
[LiteratureReference:9711845] Identification of a novel HIP1-ALK fusion variant in Non-Small-Cell Lung Cancer (NSCLC) and discovery of ALK I1171 (I1171N/S) mutations in two ALK-rearranged NSCLC patients with resistance to Alectinib
[LiteratureReference:6800632] BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition
[LiteratureReference:9634497] HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib
[LiteratureReference:9647361] Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer
[LiteratureReference:9711768] Kinase fusions are frequent in Spitz tumours and spitzoid melanomas
[LiteratureReference:9701980] STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion
[LiteratureReference:9700301] Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
[LiteratureReference:9713415] Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization

schemaClass Person

surname Ross

© 2025 Reactome

Cite Us!